Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide

Ann Intern Med. 2004 Feb 17;140(4):314-5. doi: 10.7326/0003-4819-140-4-200402170-00028.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • ADAM Proteins
  • ADAMTS13 Protein
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Cyclophosphamide / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Metalloendopeptidases / deficiency
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Purpura, Thrombotic Thrombocytopenic / etiology
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAMTS13 Protein
  • ADAMTS13 protein, human